Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Other Accumulated Expenses (2016 - 2025)

Ultralife (ULBI) has 15 years of Other Accumulated Expenses data on record, last reported at $12.8 million in Q3 2025.

  • For Q3 2025, Other Accumulated Expenses rose 44.15% year-over-year to $12.8 million; the TTM value through Sep 2025 reached $12.8 million, up 44.15%, while the annual FY2024 figure was $9.5 million, 30.1% up from the prior year.
  • Other Accumulated Expenses reached $12.8 million in Q3 2025 per ULBI's latest filing, up from $8.8 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $12.8 million in Q3 2025 and bottomed at $4.0 million in Q2 2021.
  • Average Other Accumulated Expenses over 4 years is $7.4 million, with a median of $6.9 million recorded in 2023.
  • Peak YoY movement for Other Accumulated Expenses: fell 0.87% in 2021, then surged 44.15% in 2025.
  • A 4-year view of Other Accumulated Expenses shows it stood at $6.1 million in 2021, then grew by 19.8% to $7.3 million in 2023, then surged by 30.1% to $9.5 million in 2024, then soared by 35.35% to $12.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Accumulated Expenses were $12.8 million in Q3 2025, $8.8 million in Q2 2025, and $8.6 million in Q1 2025.